Metabolic syndrome is negatively associated with cognition among endothelial nitric oxide synthase (eNOS)- 786C carriers in schizophrenia-spectrum disorders. (October 2019)

• Record Type: Journal Article
• Authors: Kraal, A. Zarina; Moll, Allison C.; Arvanitis, Nicole R.; Ward, Kristen M.; Dougherty, Ryan J.; Grove, Tyler B.; Burghardt, Kyle J.; Ellingrod, Vicki L.
• Is Part Of: Journal of psychiatric research. Volume 117(2019)
• Page Start: 142
• Page End: 147
• Publication Date: 2019-10
• Subjects: eNOS T-786C -- Cardiovascular disease -- Genes -- Metabolic syndrome -- Processing speed -- Verbal fluency -- Psychotic disorders; Psychiatry -- Periodicals; Mental Disorders -- Periodicals; Maladies mentales -- Périodiques; Psychiatry; Electronic journals; Periodicals; 616.89005
• DOI: 10.1016/j.jpsychires.2019.07.006
• Languages: English
• ISSNs: 0022-3956

Abstract

Abstract: Although metabolic syndrome and cognitive inefficiencies are well-described common complications of schizophrenia, their association remains inconsistent, potentially due to poorly understood mechanisms underlying their relationship. Variability in the endothelial nitric oxide synthase ( eNOS ) gene, specifically the T-786C variant, has been separately associated with cognition and metabolic syndrome, with worse outcomes for eNOS- 786C carriers likely occurring via negative effects on blood vessel functioning. However, the interaction between eNOS and metabolic syndrome in cognition among adults with schizophrenia is unknown. This study aimed to test the main and interaction effects of the eNOS- 786C allele in cognition using hierarchical regression analyses controlling for age, sex, education, race, and antipsychotic exposure. Metabolic syndrome, eNOS T-786C genotype, and cognitive performance were assessed in 226 community-dwelling participants with chronic schizophrenia-spectrum disorders. Results demonstrated a significant interaction between metabolic syndrome and the eNOS- 786C allele. Specifically, among eNOS- 786C carriers only, metabolic syndrome was independently associated with lower scores in processing speed and verbal fluency, and predicted 12.5% and 15.8% of variance in performance, respectively. These results suggest that the additive negative effects of eNOS- 786C and metabolic syndrome on blood vessel functioning may be severe enough to negatively impact cognition. The finding that metabolic syndrome is associated with worse cognition only in the presence of the eNOS- 786C allele may clarify extant inconsistencies in the literature. These findings provide preliminary evidence that may inform interventions to reduce cognitive morbidity among adults with schizophrenia.